<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - COVID-19 Driving Shift to Decentralized Trials
Image Overlay - COVID-19 Driving Shift to Decentralized Trials

COVID-19 Driving Shift to Decentralized Trials

COVID-19 Driving Shift to Decentralized Trials

The pandemic has meant extensive changes to all aspects of daily life, and that includes how clinical trials are conducted. COVID-19 has forced clinical trials to modernize and accommodate patients in new ways, including a shift to decentralized trials. At Yourway, we consider ourselves pioneers in decentralized and direct-to-patient trials. We’re helping to lead the charge toward a more patient-centric supply chain by providing fully integrated solutions that enable researchers and developers to bring promising therapies to market, while promoting the maintenance of patient populations by providing materials and care in a capacity convenient for them.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat
Come chat with us!
Hello! How can I help you?